(Q51021036)

English

Emerging LDL therapies: Mipomersen-antisense oligonucleotide therapy in the management of hypercholesterolemia.

scientific article published on 27 March 2013

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23642326

retrieved

27 March 2018

reference URL

http://europepmc.org/abstract/MED/23642326

title

Emerging LDL therapies: Mipomersen-antisense oligonucleotide therapy in the management of hypercholesterolemia. (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23642326

retrieved

27 March 2018

reference URL

http://europepmc.org/abstract/MED/23642326

0 references

Peter P Toth

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23642326

retrieved

27 March 2018

reference URL

http://europepmc.org/abstract/MED/23642326

language of work or name

English

0 references

publication date

27 March 2013

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23642326

retrieved

27 March 2018

reference URL

http://europepmc.org/abstract/MED/23642326

published in

Journal of Clinical Lipidology

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23642326

retrieved

27 March 2018

reference URL

http://europepmc.org/abstract/MED/23642326

volume

7

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23642326

retrieved

27 March 2018

reference URL

http://europepmc.org/abstract/MED/23642326

issue

3 Suppl

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23642326

retrieved

27 March 2018

reference URL

http://europepmc.org/abstract/MED/23642326

page(s)

S6-10

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23642326

retrieved

27 March 2018

reference URL

http://europepmc.org/abstract/MED/23642326

Identifiers

DOI

10.1016/J.JACL.2013.02.004

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23642326

retrieved

27 March 2018

reference URL

http://europepmc.org/abstract/MED/23642326

PubMed publication ID

23642326

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23642326

retrieved

27 March 2018

reference URL

http://europepmc.org/abstract/MED/23642326

ResearchGate publication ID

236662108

0 references

(Q51021036)

Emerging LDL therapies: Mipomersen-antisense oligonucleotide therapy in the management of hypercholesterolemia.

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)